Trials / Completed
CompletedNCT07044479
A Clinical Study of How Coffee and Tea Affect Enlicitide in Healthy Volunteers (MK-0616-040)
A Clinical Study to Evaluate the Effects of Coffee and Tea on the Pharmacokinetics of Enlicitide in Healthy Adult Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The goal of this study is to learn what happens to enlicitide in a person's body over time when enlicitide is taken at the same time as coffee or tea. Researchers will measure the amount of enlicitide in the blood when taken with coffee or tea compared with enlicitide taken with water.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Enlicitide | Single dose of enlicitide is administered orally on day 1 of each testing period |
Timeline
- Start date
- 2025-07-03
- Primary completion
- 2025-08-13
- Completion
- 2025-08-28
- First posted
- 2025-07-01
- Last updated
- 2025-09-03
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07044479. Inclusion in this directory is not an endorsement.